-
Forward Look
Reducing Sexual Side Effects From Prostate Cancer SurgeryReal-time tumor analysis offers assurance to surgeons seeking to preserve nerves involved in erectile function.
by Carolyn Bernhardt
-
Forward Look
Improving Breast Cancer Outcomes After SurgeryAntibody-drug conjugate improves survival in people with early-stage HER2-positive breast cancer who have residual disease.
by Susan Kreimer
-
Forward Look
Cancer ‘Fingerprint’ Drives Vaccine DevelopmentA vaccine based on a tumor’s unique genetic mutations leads to lasting immune response in locally advanced kidney cancer.
by Christina Szalinski
-
The HER2 SHIFTAntibody-drug conjugate provides an additional treatment option for people with HER2-low breast cancer.
by Kendall K. Morgan
-
Sound Advice
Does cancer treatment cause skin side effects?Patients often experience redness, itchiness, dryness and rashes, but they can take steps to prepare their skin for treatment.
-
Facts and Stats
A Shifting Cancer BurdenWomen, especially those younger than 50, are being diagnosed with cancer at an increasing rate.
by Thomas Celona
-
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood TestsAbout half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
-
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
-
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
-
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
The ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
by Darlene Dobkowski
Why I Participated in a Clinical TrialWhen doctors told Yvonne McLean Florence she was eligible to participate in a research trial testing an experimental drug, she joined. She wants more people to have the same opportunity.
by Yvonne McLean Florence
Targeted Therapy Improves Pancreatic Cancer SurvivalA recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
